New Key Statistics Module, Z-Score and F-Score
NAS:UTHR Key Ratios
| Market Cap $ M | 11,196.64 |
| Enterprise Value $ M | 8,860.66 |
| P/E(ttm) | 11.99 |
| PE Ratio without NRI | 11.99 |
| Forward PE Ratio | 10.43 |
| Price/Book | 1.87 |
| Price/Sales | 5.10 |
| Price/Free Cash Flow | 15.77 |
| Price/Owner Earnings | 14.26 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,327.00 |
| EPS (TTM) $ | 19.84 |
| Beneish M-Score | -2.03 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 30.80 |
| EV-to-EBIT | 6.64 |
| EV-to-EBITDA | 6.39 |
| PEG | -- |
| Shares Outstanding M | 47.06 |
| Net Margin (%) | 42.31 |
| Operating Margin % | 50.91 |
| Pre-tax Margin (%) | 54.75 |
| Quick Ratio | 4.28 |
| Current Ratio | 4.41 |
| ROA % (ttm) | 14.80 |
| ROE % (ttm) | 18.22 |
| ROIC % (ttm) | 25.40 |
| Dividend Yield % | -- |
| Altman Z-Score | 8.24 |
| Piotroski F-Score | 5.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | N |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | Y |
UTHR Number of Guru Trades
UTHR Volume of Guru Trades
Gurus Latest Trades with NAS:UTHR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:UTHR is held by these investors
Total 6
United Therapeutics Corp Insider Transactions
No Available Data
News about NAS:UTHR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers